• What Are the Latest Advances in Screening Tools and Treatments of Bipolar Disorder?

  • Apr 30 2024
  • Durée: 20 min
  • Podcast

Page de couverture de What Are the Latest Advances in Screening Tools and Treatments of Bipolar Disorder?

What Are the Latest Advances in Screening Tools and Treatments of Bipolar Disorder?

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Drs Trisha Suppes and Roger S. McIntyre discuss screening tools for bipolar disorder, treatment advances, and the impact of clues such as inflammation on this diagnosis.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/999799). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Bipolar Disorder https://emedicine.medscape.com/article/286342-overview

    Crosstalk Between Existential Phenomenological Psychotherapy and Neurological Sciences in Mood and Anxiety Disorders https://pubmed.ncbi.nlm.nih.gov/33801765/

    Psychedelics in the Treatment of Unipolar and Bipolar Depression https://pubmed.ncbi.nlm.nih.gov/35788817/

    Inflammatory Signaling Mechanisms in Bipolar Disorder https://pubmed.ncbi.nlm.nih.gov/34112182/

    The Rapid Mood Screener (RMS): A Novel and Pragmatic Screener for Bipolar I Disorder https://pubmed.ncbi.nlm.nih.gov/33300813/

    Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia https://pubmed.ncbi.nlm.nih.gov/5409569/

    Rapid Mood Screener https://www.rapidmoodscreener.com/
    Voir plus Voir moins
activate_primeday_promo_in_buybox_DT
Voir plus Voir moins

Ce que les auditeurs disent de What Are the Latest Advances in Screening Tools and Treatments of Bipolar Disorder?

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.